News of Note—Japanese robotics company Riverfield bags $10M; Abbott earns CE mark for next-gen stent

News of note

> Japanese robotics player Riverfield scored 1.15 billion yen ($10.1 million) in new financing to fuel its mission to undercut Intuitive Surgical. Nikkei Asian Review article

> Abbott received a CE mark for its next-generation drug-eluting stent, the Xience Sierra. Improvements include better flexibility, a thinner profile and smaller diameters. Drug Delivery Business News article

> The Chinese FDA approved Allergan’s eye implant for the treatment of macular edema that follows branch retinal vein occlusion or central retinal vein occlusion. Release

Whitepaper

Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Suggested Articles

A mesh of integrated, electric sensors aims to track the earliest stages of tissue development and differentiation.

The FDA broadened its approvals of several transcatheter aortic valve replacements to include patients at a low risk of surgical complications.

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.